Avoro Capital Advisors’s BioDelivery Sciences International, Inc. BDSI Stock Holding History

Avoro Capital Advisors’s Portfolio BDSI Stock Details BDSI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-2,034,900	Closed	-$8.87M	–	54
2020 Q2	$8.87M	Sell	2,034,900 -965,100	-32%	-$4.34M	0.18%	42
2020 Q1	$11.4M	Hold	3,000,000	–	–	0.38%	32
2019 Q4	$19M	Sell	3,000,000 -4,424,867	-60%	-$26M	0.56%	24
2019 Q3	$31.3M	Hold	7,424,867	–	–	1.3%	19
2019 Q2	$34.5M	Hold	7,424,867	–	–	1.19%	20
2019 Q1	$39.4M	Buy	7,424,867 +2,699,867	+57%	+$12.3M	1.7%	17
2018 Q4	$17.5M	Sell	4,725,000 -712,779	-13%	-$2.5M	1.05%	19
2018 Q3	$15.2M	Hold	5,437,779	–	–	0.7%	25
2018 Q2	$16M	Hold	5,437,779	–	–	0.62%	29
2018 Q1	$12.2M	Buy	5,437,779 +2,968,291	+120%	+$6.95M	0.58%	28
2017 Q4	$7.29M	Buy	+2,469,488	New	+$6.83M	0.47%	32
2017 Q1	–	Sell	-644,176	Closed	-$1.13M	–	55
2016 Q4	$1.13M	Buy	+644,176	New	+$1.32M	0.23%	37

Other funds holding BDSI

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

SFM

Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Avoro Capital Advisors's BDSI Position: Q3 2020 in Review

Avoro Capital Advisors sold out of BioDelivery Sciences International, Inc. (BDSI) in Q3 2020, closing a stake of 2,034,900 shares — an estimated $8.87M sold.

Avoro Capital Advisors first reported a position in BDSI in Q4 2016 and held it in 12 quarters. The position peaked at $39.4M in Q1 2019. 147 funds tracked by Wall St. Rank hold BDSI as of Q3 2020.

Avoro Capital Advisors reported no remaining BioDelivery Sciences International, Inc. position as of Q3 2020 after selling out during the quarter.
Avoro Capital Advisors sold 2,034,900 BioDelivery Sciences International, Inc. shares in Q3 2020, an estimated $8.87M.
Avoro Capital Advisors first reported a position in BioDelivery Sciences International, Inc. in Q4 2016 and held it in 12 quarters.
Avoro Capital Advisors's BioDelivery Sciences International, Inc. position peaked at $39.4M in Q1 2019.
147 funds tracked by Wall St. Rank held BioDelivery Sciences International, Inc. as of Q3 2020.

Based on Avoro Capital Advisors's 13F filing for Q3 2020, filed 16 Nov 2020.